Trexquant Investment’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.8M | Sell |
77,280
-18,177
| -19% | -$4.03M | 0.12% | 199 |
|
|
2025
Q4 | $21.8M | Buy |
95,457
+52,309
| +121% | +$11.9M | 0.19% | 96 |
|
|
2025
Q3 | $9.99M | Sell |
43,148
-126,831
| -75% | -$25.8M | 0.1% | 280 |
|
|
2025
Q2 | $31.6M | Buy |
+169,979
| New | +$31.6M | 0.36% | 30 |
|
|
2023
Q4 | – | Sell |
-35,483
| Closed | -$5.29M | – | 1372 |
|
|
2023
Q3 | $5.29M | Sell |
35,483
-141,956
| -80% | -$20.8M | 0.13% | 218 |
|
|
2023
Q2 | $23.9M | Buy |
+177,439
| New | +$26M | 0.63% | 14 |
|
|
2022
Q3 | – | Sell |
-4,475
| Closed | -$685K | – | 1306 |
|
|
2022
Q2 | $685K | Buy |
+4,475
| New | +$684K | 0.03% | 669 |
|
|
2021
Q4 | – | Sell |
-60,519
| Closed | -$6.53M | – | 1255 |
|
|
2021
Q3 | $6.53M | Buy |
60,519
+4,087
| +7% | +$467K | 0.52% | 24 |
|
|
2021
Q2 | $6.36M | Buy |
+56,432
| New | +$6.36M | 0.54% | 27 |
|
|
2021
Q1 | – | Sell |
-23,964
| Closed | -$2.57M | – | 1077 |
|
|
2020
Q4 | $2.57M | Buy |
+23,964
| New | +$2.3M | 0.27% | 93 |
|
|
2020
Q3 | – | Sell |
-9,595
| Closed | -$942K | – | 1152 |
|
|
2020
Q2 | $942K | Sell |
9,595
-50,353
| -84% | -$4.43M | 0.07% | 417 |
|
|
2020
Q1 | $4.57M | Buy |
59,948
+28,787
| +92% | +$2.45M | 0.33% | 49 |
|
|
2019
Q4 | $2.76M | Sell |
31,161
-30,483
| -49% | -$2.53M | 0.16% | 185 |
|
|
2019
Q3 | $4.67M | Sell |
61,644
-2,607
| -4% | -$179K | 0.4% | 65 |
|
|
2019
Q2 | $4.67M | Buy |
+64,251
| New | +$5.05M | 0.42% | 55 |
|
|
2018
Q4 | – | Sell |
-25,496
| Closed | -$2.41M | – | 1002 |
|
|
2018
Q3 | $2.41M | Sell |
25,496
-29,659
| -54% | -$2.81M | 0.18% | 174 |
|
|
2018
Q2 | $5.11M | Buy |
55,155
+962
| +2% | +$94K | 0.35% | 66 |
|
|
2018
Q1 | $5.13M | Buy |
+54,193
| New | +$5.95M | 0.36% | 43 |
|
|
2017
Q3 | – | Sell |
-15,700
| Closed | -$1.14M | – | 728 |
|
|
2017
Q2 | $1.14M | Sell |
15,700
-4,700
| -23% | -$316K | 0.31% | 52 |
|
|
2017
Q1 | $1.33M | Buy |
20,400
+16,900
| +483% | +$1.06M | 0.17% | 155 |
|
|
2016
Q4 | $219K | Sell |
3,500
-18,500
| -84% | -$1.13M | 0.03% | 781 |
|
|
2016
Q3 | $1.39M | Buy |
+22,000
| New | +$1.42M | 0.31% | 70 |
|
|
2016
Q2 | – | Sell |
-5,500
| Closed | -$314K | – | 832 |
|
|
2016
Q1 | $314K | Sell |
5,500
-39,300
| -88% | -$2.19M | 0.04% | 721 |
|
|
2015
Q4 | $2.65M | Sell |
44,800
-11,500
| -20% | -$662K | 0.23% | 95 |
|
|
2015
Q3 | $3.06M | Buy |
56,300
+39,500
| +235% | +$2.57M | 0.26% | 58 |
|
|
2015
Q2 | $1.13M | Sell |
16,800
-5,800
| -26% | -$379K | 0.13% | 282 |
|
|
2015
Q1 | $1.32M | Buy |
+22,600
| New | +$1.37M | 0.14% | 253 |
|
Other funds holding ABBV
VCM
VPM
Trexquant Investment's ABBV Position: Q1 2026 in Review
Trexquant Investment reduced its AbbVie (ABBV) stake by 19% in Q1 2026, selling an estimated $4.03M and leaving 77,280 shares worth $16.8M. The position accounts for 0.12% of the portfolio, ranked #199.
Trexquant Investment first reported a position in ABBV in Q1 2015 and has held it in 27 quarters since. The position peaked at $31.6M in Q2 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Trexquant Investment held 77,280 shares of AbbVie worth $16.8M as of Q1 2026.
- Trexquant Investment sold 18,177 AbbVie shares in Q1 2026, an estimated $4.03M.
- AbbVie made up 0.12% of Trexquant Investment's portfolio in Q1 2026, its #199 holding.
- Trexquant Investment first reported a position in AbbVie in Q1 2015 and has held it in 27 quarters since.
- Trexquant Investment's AbbVie position peaked at $31.6M in Q2 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.